Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

OBJECTIVE: The concept of using naturally occurring compounds such as polyenylphosphatidylcholine (PPC) as an adjunctive therapy to treat non-alcoholic fatty liver disease (NAFLD) and alleviate or reverse hepatic steatosis appears a very attractive option for liver protection. We aim to evaluate if...

Descripción completa

Detalles Bibliográficos
Autores principales: Maev, Igor V, Samsonov, Aleksey A, Palgova, Liudmila K, Pavlov, Chavdar S, Vovk, Elena I, Shirokova, Elena N, Starostin, Kirill M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011021/
https://www.ncbi.nlm.nih.gov/pubmed/32095253
http://dx.doi.org/10.1136/bmjgast-2019-000341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011021/
https://www.ncbi.nlm.nih.gov/pubmed/32095253
http://dx.doi.org/10.1136/bmjgast-2019-000341

Ejemplares similares